296 related articles for article (PubMed ID: 35298520)
1. How to prepare stool banks for an appropriate response to the ongoing COVID-19 pandemic: Experiences in the Netherlands and a retrospective comparative cohort study for faecal microbiota transplantation.
Groenewegen B; van Lingen E; Ooijevaar RE; Wessels E; Feltkamp MCW; Boeije-Koppenol E; Verspaget HW; Kuijper EJ; van Prehn J; Keller JJ; Terveer EM;
PLoS One; 2022; 17(3):e0265426. PubMed ID: 35298520
[TBL] [Abstract][Full Text] [Related]
2. [Reconsidering the technical aspects and quality management background of faecal microbiota transplantation due to the novel coronavirus pandemic].
Nagy GG; Tudlik Z; Gergely L; Kónya J; Orosi P; Rákóczi É; Szabó J; Várvölgyi C; Vitális E; Paragh G
Orv Hetil; 2020 Nov; 161(44):1858-1871. PubMed ID: 33130602
[TBL] [Abstract][Full Text] [Related]
3. Fecal Microbiota Transplantation for Recurrent C difficile Infection During the COVID-19 Pandemic: Experience and Recommendations.
Khanna S; Tande A; Rubin DT; Khoruts A; Kahn SA; Pardi DS
Mayo Clin Proc; 2021 Jun; 96(6):1418-1425. PubMed ID: 34088413
[TBL] [Abstract][Full Text] [Related]
4. Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study.
Ianiro G; Bibbò S; Masucci L; Quaranta G; Porcari S; Settanni CR; Lopetuso LR; Fantoni M; Sanguinetti M; Gasbarrini A; Cammarota G
Dig Liver Dis; 2020 Dec; 52(12):1390-1395. PubMed ID: 33004295
[TBL] [Abstract][Full Text] [Related]
5. Faecal microbiota transplantation for
Terveer EM; Vendrik KE; Ooijevaar RE; Lingen EV; Boeije-Koppenol E; Nood EV; Goorhuis A; Bauer MP; van Beurden YH; Dijkgraaf MG; Mulder CJ; Vandenbroucke-Grauls CM; Seegers JF; van Prehn J; Verspaget HW; Kuijper EJ; Keller JJ
United European Gastroenterol J; 2020 Dec; 8(10):1236-1247. PubMed ID: 32990503
[TBL] [Abstract][Full Text] [Related]
6. The success of fecal microbial transplantation in
Park H; Laffin MR; Jovel J; Millan B; Hyun JE; Hotte N; Kao D; Madsen KL
Gut Microbes; 2019; 10(6):676-687. PubMed ID: 30866714
[No Abstract] [Full Text] [Related]
7. Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic.
Ianiro G; Mullish BH; Kelly CR; Kassam Z; Kuijper EJ; Ng SC; Iqbal TH; Allegretti JR; Bibbò S; Sokol H; Zhang F; Fischer M; Costello SP; Keller JJ; Masucci L; van Prehn J; Quaranta G; Quraishi MN; Segal J; Kao D; Satokari R; Sanguinetti M; Tilg H; Gasbarrini A; Cammarota G
Gut; 2020 Sep; 69(9):1555-1563. PubMed ID: 32620549
[TBL] [Abstract][Full Text] [Related]
8. Stool Banking for Fecal Microbiota Transplantation: Methods and Operations at a Large Stool Bank.
Chen J; Zaman A; Ramakrishna B; Olesen SW
Front Cell Infect Microbiol; 2021; 11():622949. PubMed ID: 33937092
[TBL] [Abstract][Full Text] [Related]
9. Establishing a Fecal Microbiota Transplant Service for the Treatment of Clostridium difficile Infection.
Costello SP; Tucker EC; La Brooy J; Schoeman MN; Andrews JM
Clin Infect Dis; 2016 Apr; 62(7):908-14. PubMed ID: 26628567
[TBL] [Abstract][Full Text] [Related]
10. Faecal microbiota transplant for recurrent Clostridium difficile infection using long-term frozen stool is effective: clinical efficacy and bacterial viability data.
Costello SP; Conlon MA; Vuaran MS; Roberts-Thomson IC; Andrews JM
Aliment Pharmacol Ther; 2015 Oct; 42(8):1011-8. PubMed ID: 26264455
[TBL] [Abstract][Full Text] [Related]
11. Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation.
Staley C; Kelly CR; Brandt LJ; Khoruts A; Sadowsky MJ
mBio; 2016 Dec; 7(6):. PubMed ID: 27999162
[TBL] [Abstract][Full Text] [Related]
12. Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent
Mullish BH; McDonald JAK; Pechlivanis A; Allegretti JR; Kao D; Barker GF; Kapila D; Petrof EO; Joyce SA; Gahan CGM; Glegola-Madejska I; Williams HRT; Holmes E; Clarke TB; Thursz MR; Marchesi JR
Gut; 2019 Oct; 68(10):1791-1800. PubMed ID: 30816855
[TBL] [Abstract][Full Text] [Related]
13. Transmission and clearance of potential procarcinogenic bacteria during fecal microbiota transplantation for recurrent Clostridioides difficile.
Drewes JL; Corona A; Sanchez U; Fan Y; Hourigan SK; Weidner M; Sidhu SD; Simner PJ; Wang H; Timp W; Oliva-Hemker M; Sears CL
JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31578306
[TBL] [Abstract][Full Text] [Related]
14. International consensus conference on stool banking for faecal microbiota transplantation in clinical practice.
Cammarota G; Ianiro G; Kelly CR; Mullish BH; Allegretti JR; Kassam Z; Putignani L; Fischer M; Keller JJ; Costello SP; Sokol H; Kump P; Satokari R; Kahn SA; Kao D; Arkkila P; Kuijper EJ; Vehreschild MJG; Pintus C; Lopetuso L; Masucci L; Scaldaferri F; Terveer EM; Nieuwdorp M; López-Sanromán A; Kupcinskas J; Hart A; Tilg H; Gasbarrini A
Gut; 2019 Dec; 68(12):2111-2121. PubMed ID: 31563878
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive approach to stool donor screening for faecal microbiota transplantation in China.
He J; He X; Ma Y; Yang L; Fang H; Shang S; Xia H; Lian G; Tang H; Wang Q; Wang J; Lin Z; Wen J; Liu Y; Zhai C; Wang W; Jiang X; Xuan J; Liu M; Lu S; Li X; Wang H; Ouyang C; Cao M; Lin A; Zhang B; Wu D; Chen Y; Xiao C
Microb Cell Fact; 2021 Nov; 20(1):216. PubMed ID: 34838016
[TBL] [Abstract][Full Text] [Related]
16. Updates and Challenges in Fecal Microbiota Transplantation for Clostridioides difficile Infection in Children.
Hourigan SK; Nicholson MR; Kahn SA; Kellermayer R
J Pediatr Gastroenterol Nutr; 2021 Oct; 73(4):430-432. PubMed ID: 34238831
[TBL] [Abstract][Full Text] [Related]
17. Small Intestinal Bacterial Overgrowth: Should Screening Be Included in the Pre-fecal Microbiota Transplantation Evaluation?
Allegretti JR; Kassam Z; Chan WW
Dig Dis Sci; 2018 Jan; 63(1):193-197. PubMed ID: 29188472
[TBL] [Abstract][Full Text] [Related]
18. Donor, patient age and exposure to antibiotics are associated with the outcome of faecal microbiota transplantation for recurrent Clostridioides difficile infection: A prospective cohort study.
Baunwall SMD; Hansen MM; Andreasen SE; Eriksen MK; Rågård N; Kelsen J; Grosen AK; Mikkelsen S; Erikstrup C; Dahlerup JF; Hvas CL
Aliment Pharmacol Ther; 2023 Sep; 58(5):503-515. PubMed ID: 37482926
[TBL] [Abstract][Full Text] [Related]
19. Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.
Kelly CR; Khoruts A; Staley C; Sadowsky MJ; Abd M; Alani M; Bakow B; Curran P; McKenney J; Tisch A; Reinert SE; Machan JT; Brandt LJ
Ann Intern Med; 2016 Nov; 165(9):609-616. PubMed ID: 27547925
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors for Gastrointestinal Symptoms Following Successful Eradication of Clostridium difficile by Fecal Microbiota Transplantation (FMT).
Allegretti JR; Kassam Z; Fischer M; Kelly C; Chan WW
J Clin Gastroenterol; 2019 Oct; 53(9):e405-e408. PubMed ID: 30882536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
